---
title: "Roche H1 Profit Drops On Lower Revenues"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293565355.md"
description: "Roche Holding AG reported a 7% decline in first-half net earnings to 6.871 billion Swiss francs, driven by weak revenues. Total revenue fell 1% to 31.452 billion francs. However, on a constant currency basis, sales increased 6%, supported by demand for innovative medicines and diagnostics."
datetime: "2026-07-23T05:59:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293565355.md)
  - [en](https://longbridge.com/en/news/293565355.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293565355.md)
generator: "portal-rs"
---

# Roche H1 Profit Drops On Lower Revenues

Add  as your preferred news source on Google

 Add Now

Swiss healthcare major Roche Holding AG (RHHBY,RO.SW) reported Thursday lower profit in its first half with weak revenues.

Net earnings attributable to Roche shareholders reached 6.871 billion Swiss francs, representing a 7 percent decline from 7.410 billion francs a year ago. Earnings per share decreased 8 percent to 8.52 francs from 9.23 francs last year.

Core net income attributable to Roche shareholders totaled 8.750 billion francs, compared to 8.90 billion francs a year ago. Core earnings per share declined 2 percent to 10.85 francs from 11.08 francs last year.

Core operating profit reached 11.856 billion francs, down 1 percent year-over-year. 

Total revenue decreased 1 percent to 31.452 billion francs from 31.849 billion francs last year. Sales totaled 30.364 billion francs, representing a 2 percent decline in reported currency.

On a constant currency basis, sales increased 6 percent, driven by demand for innovative medicines and diagnostics. Sales grew 8 percent in US dollar terms.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com. 

For comments and feedback contact: editorial@rttnews.com

Business News

### Related Stocks

- [RHHBY.US](https://longbridge.com/en/quote/RHHBY.US.md)
- [RHHVF.US](https://longbridge.com/en/quote/RHHVF.US.md)

## Related News & Research

- [BioNTech Kills a Cancer Trial Roche Helped Build](https://longbridge.com/en/news/297359309.md)
- [Qiagen owes 10x, Roche $4.8 million for infringing patents, U.S. jury says](https://longbridge.com/en/news/297370596.md)
- [BioNTech to terminate mid-stage trial of mRNA cancer vaccine](https://longbridge.com/en/news/297334714.md)
- [Duality Biotherapeutics Strikes Billion-Dollar ADC Collaboration with Genentech](https://longbridge.com/en/news/297255082.md)
- [Roche (SWX:ROG) Stock Margin Expansion To 19.6% Tests Bullish Earnings Narratives](https://longbridge.com/en/news/293799255.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**